Brett A. Giffin
Chief Commercial Officer, T2 Biosystems, Inc.
Companies
- T2 Biosystems, Inc.Chief Commercial Officer Nov 15, 2021 to Jan 2, 20251
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- T2 Biosystems, Inc.77 shares2Feb 20, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 20, 2024Exercised options 13 shares of T2 Biosystems, Inc.2
- Nov 8, 2023Exercised options 33 shares of T2 Biosystems, Inc.3
- Feb 22, 2023Sold 537 shares at $0.65 of T2 Biosystems, Inc.4
- Feb 20, 2023Sold 537 shares at $0.65 of T2 Biosystems, Inc.5
- Feb 20, 2023Exercised options 1,333 shares of T2 Biosystems, Inc.4
- Feb 20, 2023Exercised options 1,333 shares of T2 Biosystems, Inc.5
- Nov 10, 2022Sold 1,292 shares at $1.79 of T2 Biosystems, Inc.6
- Nov 8, 2022Exercised options 3,333 shares of T2 Biosystems, Inc.6
- Apr 8, 2022Bought 10,600 shares at $0.49 of T2 Biosystems, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Nov 28, 2023
- 4SEC EDGARForm 4 filed Mar 9, 2023
- 5SEC EDGARForm 4 filed Nov 28, 2023
- 6SEC EDGARForm 4 filed Nov 22, 2022
- 7SEC EDGARForm 4 filed Apr 11, 2022